Newwill Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 14 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 59.02%
- Profit Growth 62.93%
- Ebitda 52.13%
- Net Worth 47.34%
- Total Assets 67.18%
About Newwill Biotech
Newwill Biotech Private Limited (NBPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 August 2010 and has a history of 14 years and five months. Its registered office is in Bangaluru, Karnataka, India.
The Corporate was formerly known as Nuwill Biotech Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Cattamanchi Latha, Hemashree Gunjuru, and Vibha Reddy serve as directors at the Company.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51909KA2010PTC055001
-
Company No.
055001
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
30 Aug 2010
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Newwill Biotech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Cattamanchi Latha
|
Director | 28-Jan-2011 | Current |
|
Hemashree Gunjuru
|
Director | 06-May-2015 | Current |
|
Vibha Reddy
|
Director | 20-Sep-2019 | Current |
Financial Performance of Newwill Biotech.
Newwill Biotech Private Limited, for the financial year ended 2016, experienced significant growth in revenue, with a 59.02% increase. The company also saw a substantial improvement in profitability, with a 62.93% increase in profit. The company's net worth Soared by an impressive increase of 47.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Newwill Biotech?
In 2017, Newwill Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Newwill Biotech?
Newwill Biotech has a workforce of 6 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Newwill Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Newwill Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
